Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

Chief Executive Officer

Lexaria Bioscience Corp. operates as a biotechnology company. The company develops and out-licenses its DehydraTECH combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and various cannabinoids. The company's DehydraTECH technology evaluates for a variety of therapeutic indications, including hypertension, heart disease, dementia, and diabetes. It is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is based in Kelowna, Canada.

Lexaria Bioscience Corp. operates as a biotechnology company.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-02-09	Premium	bought	Premium	Premium	Premium	-
2022-10-14	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2022-10-14	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-10-13	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-10-13	Premium	acquired	Premium	Premium	Premium	CEO
2022-10-12	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-10-12	Premium	acquired	Premium	Premium	Premium	CEO
2022-05-24	Premium	acquired	Premium	Premium	Premium	-
2022-05-20	Premium	acquired	Premium	Premium	Premium	-
2022-05-19	Premium	acquired	Premium	Premium	Premium	-
2022-05-18	Premium	acquired	Premium	Premium	Premium	-

LEXX - Lexaria Bioscience Corp. Stock Price, Fair Value and News

Latest Insider Trading transactions for LEXX